About
Lyra Medical develops a safe way to implant an organ-support mechanism in women suffering from pelvic organ prolapse. The company's Self-Retaining Support technology is used in the flagship Lyra system for anterior vaginal wall, apex, and uterine prolapse. The support platform may also be applicable in other pelvic organ disorder conditions, including rectocele and urinary incontinence, as well as other clinical areas such as hernias. Lyra Medical has a robust IP portfolio, including approved US and EU patents and pending applications in other regions. Lyra has completed two clinical studies, with a total of 70 patients, showing excellent results. The company is obtaining EU and Israeli regulatory approval (CE mark and AMAR) with a product launch in Israel and strategic EU markets to follow. Lyra has signed an international distribution agreement with an EU-based strategic partner.
Funding history · 1 round · — total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Lyra Medical's primary focus?
- Lyra Medical develops and implants organ-support mechanisms for women with pelvic organ prolapse, utilizing its Self-Retaining Support technology.
- When was Lyra Medical founded?
- Lyra Medical was founded in July 2011.
- What is the current employee count for Lyra Medical?
- Lyra Medical currently has 5 employees.
- Has Lyra Medical completed any clinical studies?
- Yes, Lyra Medical has completed two clinical studies involving a total of 70 patients, reporting excellent results.
- What regulatory approvals is Lyra Medical pursuing?
- Lyra Medical is in the process of obtaining EU (CE mark) and Israeli (AMAR) regulatory approvals.
- Has Lyra Medical secured any distribution agreements?
- Yes, Lyra Medical has signed an international distribution agreement with an EU-based strategic partner.
- When did Lyra Medical secure additional funding for clinical and regulatory efforts?
- In January 2016, Lyra Medical secured additional funding to support its clinical and regulatory affairs efforts for its pelvic organ prolapse treatment technology.
- Does Lyra Medical hold any patents?
- Yes, Lyra Medical has a robust IP portfolio, including approved US and EU patents and pending applications in other regions.